Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sorrento Therapeutics Inc
(NQ:
SRNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sorrento Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Market Briefing For Monday, Aug. 2
August 02, 2021
We're 'not' in a global financial crisis; but we are failing the 'synchronized global recovery', due to the worldwide pandemic.
Via
Talk Markets
Market Briefing For Thursday, July 29
July 29, 2021
Disarming SARS-CoV-2 with pharmaceutical drugs is the 'holy grail' to end the COVID-19 panic, and generally eliminate the panic pressures for vaccines.
Via
Talk Markets
Exposures
COVID-19
Market Briefing For Wednesday, July 28
July 28, 2021
Tolls being taken out of the market for those overstaying not just Chinese stocks, but the S&P and NDX behemoths as well. Solid earnings are 'in the mix' (discounted) of course, and it's the guidance...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Briefing For Thursday, July 22
July 22, 2021
The post-COVID era has not arrived yet, and that cuts to the chase of what's bothering markets and prospects for the economy. The optimistic hope is to keep everything open on a presumed basis, because...
Via
Talk Markets
Topics
Economy
Exposures
Economy
Unusual Options Activity Insight: Sorrento Therapeutics
July 21, 2021
Shares of Sorrento Therapeutics (NASDAQ:SRNE) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $9.16. Sentiment:...
Via
Benzinga
Why Sorrento Therapeutics' Stock Is Trading Higher Today
July 21, 2021
Sorrento Therapeutics (NASDAQ:SRNE) shares are trading hig...
Via
Benzinga
Market Briefing For Wednesday, July 21
July 21, 2021
Via
Talk Markets
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
July 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Sorrento Starts Patient Dosing In Mid-Stage COVID-19 Trial With Nasal Neutralizing Antibody
July 21, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) has started dosing COVID-19 patients in its Phase 2 efficacy trial. This study uses a decentralized design where...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Wednesday, July 14
July 14, 2021
Negative divergences increasingly creeping into the NY market are reflected a good bit by the S&P shuffles, and overall big-board technicals. Though, yields were up with a mediocre Treasury Auction,...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Unusual Options Activity Insight: Sorrento Therapeutics
July 12, 2021
On Monday, shares of Sorrento Therapeutics (NASDAQ:SRNE) saw unusual options activity. After the option alert, the stock price moved down to $8.31. Sentiment: BULLISH Option...
Via
Benzinga
Why Sorrento Therapeutics Is Down 9% This Week
July 08, 2021
Investors apparently weren't impressed by good news about the company's promising RTX.
Via
The Motley Fool
Why Sorrento Therapeutics Stock Gained 29% Last Month
July 08, 2021
The rally has more to do with the stock's pre-June circumstances than recent news.
Via
The Motley Fool
Exposures
COVID-19
Market Briefing For Thursday, July 8
July 08, 2021
Economic instability was a concern of the FOMC Minutes, with debates as to whether or not the country is recovering faster than they expected.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 07, 2021
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT
Via
Benzinga
Sorrento To Start Testing Non-Opioid Candidate In Osteoarthritis-Related Knee Pain
July 07, 2021
The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) Phase 2 study of Resiniferatoxin (RTX) for moderate-to-severe osteoarthritis of the knee pain...
Via
Benzinga
Exposures
Product Safety
Why Sorrento Therapeutics Is Climbing Today
July 01, 2021
Rising numbers of new COVID-19 cases might have investors anticipating strong demand for the company's 15-minute test.
Via
The Motley Fool
Exposures
COVID-19
Cramer Gives His Opinion On Virgin Galactic, Zynex And More
July 01, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Virgin Galactic Holdings Inc (NYSE: SPCE) is a very expensive stock. It had a nice run, but he would look for...
Via
Benzinga
Market Briefing For Thursday, July 1
July 01, 2021
The second quarter of 2021 concluded on a high note, a new record S&P high, which was a part of Wednesday's rotational action focused primarily on big cap stocks influential enough to contribute to the...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Sorrento Therapeutics Forms Bullish Pattern, Options Traders Place Bets
June 28, 2021
Sorrento Therapeutics, Inc (NASDAQ:SRNE) shot up over 10% ...
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
June 25, 2021
Gainers Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) rose 83.4% to $16.34 in pre-market trading after the company reported a sharp rise in Q1 earnings and sales. Grove, Inc. (...
Via
Benzinga
Why Sorrento Therapeutics Stock Jumped 10.6% Today
June 24, 2021
The company is setting up a subsidiary to launch its COVID-19 test in Mexico.
Via
The Motley Fool
Exposures
COVID-19
The News That Has Sorrento Therapeutics Trading Higher Today
June 24, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) is trading higher Thursday after the company received EUA approval and a product import license from COFEPRIS for its rapid COVID-19 test...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Thursday, Jun. 24
June 24, 2021
Around record S&P levels, discussions drone-on about crypto or the Fed, and inflation, along with vague discussions about returning risk from COVID.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Market Briefing For Wednesday, Jun. 23
June 23, 2021
The attractiveness of stocks and sectors vary so widely now, that most bull / bear debates are somewhat academic, even though logic for a correction is there.
Via
Talk Markets
Sorrento Therapeutics Is Forming Pennant Pattern: Technical Levels To Watch
June 22, 2021
Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares moved higher Tuesday after the company announced Phase 2 Abivertinib clinical studies have completed patient enrollment in the U.S...
Via
Benzinga
Sorrento Therapeutics Concludes Enrollment In Abivertinib Mid-Stage COVID-19 Trials In US, Brazil
June 22, 2021
Sorrento Therapeutics Inc (NASDAQ: SRNE) has completed enrollment for its Phase 2 trial of Abivertinib in hospitalized COVID-19 patients in Brazil. This...
Via
Benzinga
Exposures
COVID-19
Market Briefing For Thursday, Jun. 17
June 17, 2021
Vulnerability is bifurcated, just like sector rotation indicated all year thus far. It is typical to see risk increased amidst superficial optimism at high S&P levels, but that's not really what moved...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Briefing For Tuesday, Jun. 15
June 15, 2021
Conclusions can't be drawn about the upcoming FOMC meetings by analysts, who mostly continue to debate the issues we know: hot inflation numbers that skewed the CPI, whether that's transitory or not,...
Via
Talk Markets
Why Sorrento Therapeutics Stock Flew Nearly 7% Higher on Monday
June 14, 2021
The company got the green light to launch phase 2 testing in the U.K. for its experimental COVID-19 treatment.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.